Ac-YVAD-CMK is a selective, irreversible inhibitor of interleukin-1β converting enzyme (ICE; Caspase-1). Ac-YVAD-CMK is neuroprotective in a rat model of cerebral ischemia.
Ac-YVAD-CMK is a selective caspase-1 (IL-1beta converting enzyme, ICE)) inhibitor with neuroprotective and anti-inflammatory effects. Ac-YVAD-CMK effectively suppresses the expression of IL-1β and IL-18. Ac-YVAD-CMK inhibits pyroptosis in many diseases.
IC50&Target
Caspase-1
体外研究
Ac YVAD-CMK (40 μM or 80 μM) reduces the expression of IL-1 β and IL-18 in activated microglia cells in vitro.
体内研究
Compared with the ICH group, Ac YVAD CMK treatment (1 μg/rat; SD rats; The injection into the left ventricle significantly reduced the protein levels of caspase-1 (p20) and mature IL-1 β/IL-18.
Using logarithmic rank analysis, Ac YVAD CMK (rats receiving a dose of 12.5 μMol/kg ac YVAD cmk) significantly reduced mortality from 83% to 33%.
分子式
C24H33ClN4O8
分子量
540.99
CAS号
178603-78-6
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)